SARS-CoV-2 Genetic Diversity and Evolution

Like other coronaviruses, SARS-CoV-2 is evolving. The genomic diversity of SARS-CoV-2 strains in different countries is consistent with multiple introductions of the virus to different locations, seeding local transmission events. The papers in this feed report latest research into genetic variation and phylogeny of this highly successful virus.

May 19, 2020
Open Access

Design of multi-epitope vaccine candidate against SARS-CoV-2: a In-Silico study

Journal of Biomolecular Structure & Dynamics
Abraham Peele KVenkateswarulu Tc
May 20, 2020
Open Access

Clinical value of the emergency department in screening and diagnosis of COVID-19 in China

Journal of Zhejiang University. Science. B
Qin ZhangYuan-Qiang Lu
May 30, 2020

Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt

Microbiology Resource Announcements
Ahmed KandeilMohamed A Ali
May 30, 2020

Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence

Mayya SedovaAdam Godzik
May 26, 2020
PreprintOpen Access

Clinical Utility of SARS-CoV-2 Whole Genome Sequencing in Deciphering Source of Infection

T. TakenouchiKenjiro Kosaki
May 25, 2020
PreprintOpen Access

Spread dynamics of SARS-CoV-2 epidemic in China: a phylogenetic analysis

H. GuohuMao Qing
June 1, 2020

Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Hunduma Dinka, Ashenafi Milkesa
May 14, 2020
Open Access

Genetic variants and source of introduction of SARS-CoV-2 in South America

Journal of Medical Virology
Julio A Poterico, Orson Mestanza
May 16, 2020
PreprintOpen Access

Tracking the COVID-19 pandemic in Australia using genomics

T. SeemannBenjamin P Howden
May 14, 2020

A RT-PCR assay for the detection of coronaviruses from four genera

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Leshan XiuGregory C Gray

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved